Location History:
- Suita, JP (2014)
- Osaka, JP (2021 - 2023)
Company Filing History:
2 out of 101 
2 out of 110 
1 out of 65 Years Active: 2014-2023
Title: Hitoshi Suda: Innovator in Pharmaceutical Compounds
Introduction
Hitoshi Suda is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit β-lactamase, an enzyme that can render antibiotics ineffective. With a total of 3 patents to his name, Suda's work is crucial in the fight against bacterial infections.
Latest Patents
One of Hitoshi Suda's latest patents involves an oxo-substituted compound that exhibits an excellent β-lactamase inhibitory effect. This novel compound, represented by specific formulas, can be used either alone or in combination with β-lactam drugs to create effective preventive or therapeutic agents for bacterial infections. Additionally, the compound has potential applications in treating various diseases when used alongside β-lactam drugs.
Career Highlights
Throughout his career, Hitoshi Suda has worked with esteemed organizations such as the Kitasato Institute and Sumitomo Dainippon Pharma Co., Ltd. His experience in these institutions has allowed him to advance his research and contribute to the development of innovative pharmaceutical solutions.
Collaborations
Hitoshi Suda has collaborated with notable colleagues, including Toshio Kanai and Sachiko Koike. These partnerships have further enriched his research and innovation in the pharmaceutical field.
Conclusion
Hitoshi Suda's contributions to the development of β-lactamase inhibitors highlight his importance as an inventor in the pharmaceutical industry. His work continues to pave the way for new treatments against bacterial infections and other diseases.